Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability
Hee Ju Cho, Tag Keun Yoo Department of Urology, Eulji Hospital, Eulji University School of Medicine, Seoul, KoreaAbstract: α1-Adrenergic receptor antagonists are commonly used to treat male lower urinary tract symptoms and benign prostatic hyperplasia (BPH). We performed a literature sear...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Research and Reports in Urology |
Online Access: | http://www.dovepress.com/silodosin-for-the-treatment-of-clinical-benign-prostatic-hyperplasia-s-peer-reviewed-article-RRU |